We are live on ! Find out more
HELX icon

Franklin Genomic Advancements ETF
HELX

2 hedge funds and large institutions have $1.68M invested in Franklin Genomic Advancements ETF in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more ownership

Funds ownership: 0% → 75% (+75%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$1.69M
2
UBS Group
UBS Group
Switzerland
+$68

Top Sellers

No sellers this quarter

HELX Hedge Fund Activity: Q1 2020 in Review

2 of the 4,546 institutional investors tracked by Wall St. Rank reported a position in Franklin Genomic Advancements ETF (HELX) for Q1 2020, worth a combined $1.68M.

Buyers outnumbered sellers: 2 funds opened new HELX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $1.69M.

  • 2 institutional investors held Franklin Genomic Advancements ETF (HELX) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $1.68M of Franklin Genomic Advancements ETF stock for Q1 2020.
  • 2 funds opened new Franklin Genomic Advancements ETF positions in Q1 2020 and 0 closed out, a net change of +2 holders.
  • The largest Franklin Genomic Advancements ETF buyer in Q1 2020 was Franklin Resources, an estimated $1.69M added.

Based on aggregated 13F filings for Q1 2020.